← Return to the reading library

Product review · Sources accessed 2026-10-14

numbuzin No.5: a pure-powder statement is not a finished-formula percentage

The glutathione/TXA ampoule has a specific ingredient record and a restrictive buying policy. Its 100% powder entry requires a narrow interpretation.

An editorial reading of public records. No clinician sign-off, patient outcome study, firsthand product test or examination of a supplied medicine is claimed.

The most emphatic percentage in numbuzin’s No.5 Glutathione TXA Advanced Dark Spot Ampoule record belongs to a powder entry. That detail matters because a shopper could otherwise read one hundred percent as a description of the entire finished formula. The ingredient declaration supplies a more limited claim, which is still useful when recorded accurately.

We examined the official US listing and help pages on October 14, 2026. The selected record identified a 10 g ampoule at $24.70, with $26 shown as the regular price. This analysis does not include a purchased package, laboratory measurement or application experience. Its purpose is to make the scope of the public statements clear.

numbuzin / Ampoule: Powder component, Finished-formula question, Return restrictions
Editorial diagram of the source record. Not a product photograph or a measured clinical result.

Follow the record

Which part of the product is described as pure?

The page separates a glutathione powder entry from the other declared ingredients. Its one-hundred-percent wording applies to that powder. The complete listing also names sea-buckthorn water, tranexamic acid, glutathione, niacinamide and additional constituents. Those entries make it impossible to read the powder statement as a literal claim that the whole preparation contains nothing but glutathione. Source 1

The final glutathione and tranexamic-acid concentrations are not established by that wording. Our active-name comparison encourages retaining the ingredient name and the basis of a number together. When the basis changes from a component to a finished product, the comparison needs to say so rather than silently carrying the percentage across.

The claim names several appearance concerns

Numbuzin promotes the ampoule for the look of dark spots, post-acne marks and uneven tone. That identifies the manufacturer’s intended cosmetic positioning. It does not diagnose a reader’s discoloration or show that every concern grouped into the sales description has the same cause, appropriate care or expected response. Source 1

We did not inspect a complete controlled trial report for the marketed ampoule that establishes the relevant population, comparator and outcome measurement. The testimonial-evidence guide explains why favorable experiences cannot fill those methodological gaps. A review can acknowledge the product’s intended role without inventing a clinical success rate from its advertising.

The claim names several appearance concerns: Powder component, Finished-formula question, Return restrictions
Editorial diagram of the source record. Not a product photograph or a measured clinical result.

The sensory statements remain manufacturer descriptions

The seller calls the texture lightweight and fast absorbing, while separately warning of a pungent sulfur-like scent associated with high-purity glutathione. These statements describe what the company wants a buyer to understand before use. We have not verified either the pleasant texture language or the intensity of the scent by applying a sample. Source 1

A sensitive-skin claim does not establish that every person will tolerate the full formulation. AAD’s guidance about trying new skincare supports a careful introduction and attention to reactions. It is background guidance, not a test of this ampoule or a guarantee about its compatibility with an existing prescription or routine. Source 3

The price observation needs a destination and quantity

The $24.70 observation belongs to the 10 g item, not an independently established month of care. Shipping can change a small purchase substantially: the US FAQ lists a $7.95 standard charge below a $60 threshold after discounts. A single item under those conditions would total $32.65 before tax, but no checkout was completed for this review. Source 1 Source 2

The price-wording discussion is useful whenever an initial figure is presented without the rest of the order. Free samples, a larger basket or a destination-specific offer should be recorded as separate conditions. The ampoule’s advertised price does not verify stock, shipment completion or the quantity someone would actually use.

An unopened item is not automatically returnable

The FAQ excludes ordinary change-of-mind returns even when goods are unopened and unused. It also says allergic reactions do not qualify for refunds or returns. A damaged, defective or incorrect delivery is treated separately, with contact requested within thirty days of purchase and photographs supporting the issue. Source 2

These are materially different categories from a broad try-it-and-decide guarantee. The same FAQ excludes returns and exchanges for Canadian international orders. We did not file a claim or evaluate customer support, so the text establishes the published rules rather than how a specific customer’s request would be resolved. Read the seller-specific terms before assuming a retailer elsewhere uses the same policy.

An unopened item is not automatically returnable: Selected product, Charge and frequency, Return conditions
Editorial diagram of the source record. Not a product photograph or a measured clinical result.

The missing answer should remain visible

A complete label or written specification could improve the concentration record; an unsupported calculation cannot. The current package instructions would also matter for understanding preparation, application and storage. We did not inspect a shipped item, and a product photograph alone would not authenticate its contents or establish a reliable dose.

Our label-questions guide helps turn those gaps into precise requests. Keep the current full name and size with the question so the response concerns this ampoule rather than another No.5 product. Similar collection names are not a reason to import an ingredient list, study or purchase term from a different preparation.

A source-based conclusion is narrower than a recommendation

The record supports an identifiable cosmetic ampoule, a dated price and a particular powder claim. It also supports a clear warning that the seller’s ordinary returns are restrictive. It does not establish a verified improvement in melasma, an exact finished glutathione percentage or an independently observed texture preference.

That leaves a useful, conditional decision: determine whether the available formula information and purchase conditions are sufficient for your question. The claim directory keeps the powder-versus-product distinction available as a separate example. It is a way to inspect an assertion, not a tool for diagnosing skin or selecting a personal treatment.

Return to the documents

  1. No.5 Glutathione TXA Advanced Dark Spot Ampoule Concentrate ↗Official product or purchase terms · Accessed 2026-10-14
  2. Help & FAQ | numbuzin ↗Official product or purchase terms · Accessed 2026-10-14
  3. How to test skin care products ↗Clinical context · Accessed 2026-10-14
See every source in the register →